Maximizing Outcomes in Relapsed/Refractory Multiple Myeloma: Tailoring Bispecific Antibody Approaches : Episode 3
Implications of Talquetamab on the Current Treatment Landscape for R/R MM
Dr Mohan and Dr Mann discuss the current therapeutic landscape for relapsed/refractory multiple myeloma (R/R MM), alternative treatment strategies, and the real-world performance, advantages, and challenges of incorporating talquetamab into treatment protocols.
Video content above is prompted by the following:
- How would you describe the current therapeutic landscape for R/R MM?
- What alternative treatment strategies could have been considered for this patient?
- Based on your clinical experience, how has talquetamab performed in real-world practice?
- What advantages and challenges have you encountered when incorporating talquetamab into your treatment protocols?
Recent Videos
Related Content
